Literature DB >> 1534679

Axillobifemoral bypass and aortic exclusion for vascular septic lesions: a multicenter retrospective study of 98 cases. French University Association for Research in Surgery.

F Bacourt1, F Koskas.   

Abstract

Ninety-eight patients with aortic infection or aortoenteric fistula were treated by axillobifemoral bypasses and aortic exclusion by 22 surgical teams. Early mortality was 24%. Primary patency at two and five years was 62% and 55%, respectively. Actuarial primary patency at two and five years was 82% and 65%, respectively. The actuarial rate of limb salvage at two and five years was 90% and 82%, respectively. Eight aortic stumps ruptured in less than eight months, postoperatively. Two of these ruptures were treated with success. Infection of the axillobifemoral bypasses was observed in seven cases, six of which were treated successfully. Eight patients had axillary complications, all treated successfully without upper limb sequelae. In eight cases, the axillobifemoral bypass was replaced by a thoracic aortic bypass. Early mortality was higher after emergency operation (30%) than after elective operation (14%). Mortality after cure of primary infection (7%) was lower than after secondary infection (27%). The rate of infection in polytetrafluoroethylene axillobifemoral bypass (3%) was lower than in Dacron axillobifemoral bypass (13%). The rate of occlusion of polytetrafluoroethylene axillobifemoral bypass and Dacron axillobifemoral bypass was identical. The rate of occlusion in ringed reinforced grafts was lower (9%) than in the nonreinforced grafts (22%). The rate of occlusion was significantly higher after ablation of graft for occlusive lesions (38%) than after graft for aneurysms (7.9%) (p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534679     DOI: 10.1007/bf02042731

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  9 in total

1.  Infected aneurysm.

Authors:  Kamphol Laohapensang; Robert B Rutherford; Supapong Arworn
Journal:  Ann Vasc Dis       Date:  2010-07-21

2.  Aorto-enteric fistula: changing management strategies.

Authors:  D O Kavanagh; J F Dowdall; F Younis; S Sheehan; D Mehigan; M C Barry
Journal:  Ir J Med Sci       Date:  2006 Jan-Mar       Impact factor: 1.568

3.  Successful surgical treatment of aortoenteric fistula.

Authors:  Jang Yong Kim; Young-Wook Kim; Chel Joong Kim; Hye In Lim; Dong Ik Kim; Seung Huh
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

4.  Management of the infected aortoiliac aneurysms.

Authors:  Kamphol Laohapensang; Supapong Aworn; Saranat Orrapi; Robert B Rutherford
Journal:  Ann Vasc Dis       Date:  2012

5.  Creation of a neo-aortoiliac system from lower extremity deep and superficial veins.

Authors:  G P Clagett; B L Bowers; M A Lopez-Viego; M B Rossi; R J Valentine; S I Myers; A Chervu
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

6.  Cadaveric aorta implantation for aortic graft infection.

Authors:  Asad Ali; Sandeep S S Bahia; Tahir Ali
Journal:  Int J Surg Case Rep       Date:  2016-06-23

7.  Use of an extracorporeal bypass for renal preservation to treat a rare case of a true mycotic aneurysm in a renal transplant patient.

Authors:  Enjae Jung; Francis J Caputo; Jeffrey Jim
Journal:  J Vasc Surg Cases       Date:  2015-06-18

8.  Cryopreserved venous allograft in the treatment of a mycotic abdominal aortic aneurysm caused by group B Streptococcus.

Authors:  Tyler D Yan; Gary K Yang
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-11-17

Review 9.  Surgical management of infected thoracic aneurysms.

Authors:  Akihiko Usui
Journal:  Nagoya J Med Sci       Date:  2013-08       Impact factor: 1.131

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.